entinostat has been researched along with Sarcoma, Ewing in 3 studies
Sarcoma, Ewing: A malignant tumor of the bone which always arises in the medullary tissue, occurring more often in cylindrical bones. The tumor occurs usually before the age of 20, about twice as frequently in males as in females.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oxidative stress attenuates melanoma metastasis, and melanoma cells must reduce oxidative stress to metastasize." | 1.51 | Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasis. ( Cheng, H; Colborne, S; Cran, J; Delaidelli, A; Delattre, O; El-Naggar, AM; Gleave, M; Hughes, CS; Huntsman, DG; Kedersha, N; Mandinova, A; Morin, GB; Negri, GL; Pan, M; Rafn, B; Somasekharan, SP; Sorensen, PH; Surdez, D; Wang, XQ; Wang, Y; Zhang, F; Zhang, H, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JA | 1 |
| Crawford, KA | 1 |
| Spada, PA | 1 |
| Martin, LR | 1 |
| Zhang, J | 1 |
| Wong, R | 1 |
| Reid, JM | 1 |
| Stewart, CF | 1 |
| Frank, TM | 1 |
| Liu, Q | 1 |
| Michalek, JE | 1 |
| Keller, C | 1 |
| El-Naggar, AM | 1 |
| Somasekharan, SP | 1 |
| Wang, Y | 2 |
| Cheng, H | 1 |
| Negri, GL | 1 |
| Pan, M | 1 |
| Wang, XQ | 1 |
| Delaidelli, A | 1 |
| Rafn, B | 1 |
| Cran, J | 1 |
| Zhang, F | 1 |
| Zhang, H | 1 |
| Colborne, S | 1 |
| Gleave, M | 1 |
| Mandinova, A | 1 |
| Kedersha, N | 1 |
| Hughes, CS | 1 |
| Surdez, D | 1 |
| Delattre, O | 1 |
| Huntsman, DG | 1 |
| Morin, GB | 1 |
| Sorensen, PH | 1 |
| Sonnemann, J | 1 |
| Dreyer, L | 1 |
| Hartwig, M | 1 |
| Palani, CD | 1 |
| Hong, le TT | 1 |
| Klier, U | 1 |
| Bröker, B | 1 |
| Völker, U | 1 |
| Beck, JF | 1 |
3 other studies available for entinostat and Sarcoma, Ewing
| Article | Year |
|---|---|
Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma.
Topics: Adjuvants, Immunologic; Adjuvants, Pharmaceutic; Animals; Benzamides; Disease Models, Animal; Enoxac | 2023 |
Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasis.
Topics: Acetylation; Animals; Antineoplastic Agents; Benzamides; Bone Neoplasms; Cell Line, Tumor; Cells, Cu | 2019 |
Histone deacetylase inhibitors induce cell death and enhance the apoptosis-inducing activity of TRAIL in Ewing's sarcoma cells.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Butyrates; Caspase 3; Caspase 9; Caspases; Cell Line, | 2007 |